Institutional Ownership
Homology Medicines Inc
CUSIP 438083107COMFIXXEURQ1 2026
13D / 13G Filings
21
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
13.1%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
21 filings · latest Mar 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 14, 2024 | Adar1 Partners, LP | 13G | 5.4% | 3.12M | SEC |
| 2 | Jul 8, 2022 | Blackrock Inc. | 13G | 2.9% | 1.66M | SEC |
| 3 | Feb 14, 2022 | Temasek Holdings (Private) Ltd | 13G/A | 9.9% | 5.65M | SEC |
| 4 | Feb 3, 2022 | Blackrock Inc. | 13G/A | 6.3% | 3.59M | SEC |
| 5 | May 6, 2021 | Jpmorgan Chase & Co | 13G/A | 2.0% | 1.19M | SEC |
| 6 | Feb 16, 2021 | 5am Ventures IV, L.P. | 13G/A | 9.6% | 4.35M | SEC |
| 7 | Feb 16, 2021 | Price T Rowe Associates Inc /Md/ | 13G/A | 4.3% | 1.99M | SEC |
| 8 | Feb 12, 2021 | Rtw Investments, LP | 13G/A | — | — | SEC |
| 9 | Feb 2, 2021 | Blackrock Inc. | 13G | 6.1% | 2.76M | SEC |
| 10 | Jan 25, 2021 | Jpmorgan Chase & Co | 13G/A | 7.6% | 3.44M | SEC |
11 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Homology Medicines Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Kerr Financial Planning Corp | 600 | $0 |